Clinical Trial Update: Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark

View source ↗

Summary

Clinical trial update on raltegravir treatment for HIV-infected patients failing HAART in Denmark; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: HIV Infections | Status: COMPLETED